Editorial Conflict of Interest Disclosure

(as of May 2023)

As part of good publication practices, all editors of the JAFES (Editor-in-Chief, Vice Editor-in-Chief, Associate Editors, Editorial Board and Advisers) are required to disclose on an annual basis, any potential conflict of interest, including current or recent financial relationships with any commercial entity whose products or services may be contained in the journal content. Disclosure represents a commitment to transparency and does not necessarily indicate a bias.  This policy follows the recommendations of the International Committee of Medical Journal Editors (ICMJE) and the Committee on Publication Ethics (COPE).

The following were disclosed:

ELIZABETH PAZ-PACHECO | Editor-in-Chief | Prof. Pacheco receives grants for Metabolomics of DM Nephropathy from the Philippine Council for Health Research Development. She receives speaker fees from Sanofi and Novo Nordisk. She received a CME grant for attending the virtual meeting of the American Diabetes Association (ADA) from Sanofi. She is a Past President of the Philippine College of Endocrinology, Diabetes and Metabolism (PCEDM).

CECILIA A. JIMENO | Vice Editor-in-Chief | Prof. Jimeno receives consulting fees from Abbott Nutrition (2023 to present). She receives honoraria for lectures, presentations and as speaker of Sanofi Aventis, Merck, Novartis, MSD and Novo Nordisk. She receives travel grants for registration and accommodation from Sanofi Aventis and MSD. She received gifts for use in the clinic from LRI-Therapharma and MedChoice Pharma and she received drug samples from LRI-Therapharma, MedChoice Pharma, MSD, Sanofi, Merck and Astra Zeneca.

GABRIEL V. JASUL JR. | Associate Editor | Prof. Jasul received honoraria for lectures from Sanofi Aventis, Novo Nordisk, MSD, Boehringer Ingelheim, Abbott Nutrition, Astra Zeneca, LRI- Therapharma, UMed and Woerwag.

MADE RATNA SARASWATI | Associate Editor | Prof. Saraswati receives honoraria for lectures from Kalventis Sinergi Farma, Novo Nordisk, PT Shanghiang Perkasa (Kalbe Nutrisi) and Anugerah Pharmindo Lestari (Zuellig Pharma). She is an Advisory Board Member of Anugerah Pharmindo Lestari (Zuellig Pharma), Novo Nordisk and Kalventis Sinergi Farma.

NORLAILA MUSTAFA | Associate Editor | Prof. Mustafa receives grants from Novo Nordisk. She receives honoraria for lectures from Astra Zeneca, Novo Nordisk, Zuellig Pharma and Abbott. She receives support for attending meetings from Novo Nordisk and Sanofi. She is an Advisory Board member of Astra Zeneca and Novo Nordisk. She is a Board of Trustee of the National Diabetes Institute (NADI) and a Council Member of the Malaysian Endocrine and Metabolic Society (MEMS).

KYU KYU MAUNG | Associate Editor | Prof. Maung has nothing to disclose.

CHAICHARN DEEROCHANAWONG | Associate Editor | Prof. Deerochanawong receives honoraria for lectures from Astra, Abbott, Amgen, Novo Nordisk, Novartis, Zuellig Pharma, MSD, Merck and Celltrion. He is the current President of the Endocrine Society of Thailand (EST).

NGUYEN THY KHUE |Associate Editor | Prof. Khue receives consulting fees from Merck. She receives honoraria for lectures from Servier, Boehringer Ingelheim and Novo Nordisk. She receives fees as the Advisory Board of Kowa. She is a member of the Vietnamese Association of Diabetes and Endocrinology (VADE), Ho Chi Minh City Association of Diabetes and Endocrinology (HADE) and Ho Chi Minh City Medical Association.

MARY ANN R. ABACAN | Editorial Board Member | Prof. Abacan receives grants as co-investigator of the Registry of Lysosomal Storage Disorders from Sanofi Genyzme (2014 to present) and as co-investigator of the SHP-ELA-401 - A Long-Term, Open-Label, Multicenter, Phase IV Study to Assess Longitudinal Changes on Height and Weight in Patients with MPS II who are receiving Elaprase and started Treatment with Elaprase at <6 Years of Age - Shire (2015-present). She is a Consultant Medical Specialist at the Institute of Human Genetics at the University of the Philippines-National Institutes of Health. She is a co-chair of the National Transplant Ethics Committee of the Department of Health and the Chair of the Metabolic Experts Panel at the Newborn Screening Reference Center of the National Institutes of Health. She is a stockholder of Clinical Genetics and Genomics Counselling Care Services, Inc. She is the Chair of the Congenital and Developmental Disorders Task Force, Philippine Periodic Health Examination II - Institute of Clinical Epidemiology and DOH joint project (2021), Technical Facilitator of the Pediatric Immunization Task Force, Philippine Periodic Health Examination III - Institute of Clinical Epidemiology and DOH joint project (2023) and a Technical Facilitator of the Dengue Task Force, Philippine Periodic Health Examination III - Institute of Clinical Epidemiology and DOH joint project (2023).

LORNA R. ABAD | Editorial Board Member | Prof. Abad has nothing to disclose.

MARISSA M. ALEJANDRIA | Editorial Board Member | Prof. Alejandria has nothing to disclose.

PIA D. BAGAMASBAD | Editorial Board Member | Prof. Bagamasbad receives grants from the Department of Science and Technology-Philippine Council for Health Research Development (DOST-PCHRD) and the DOST-National Academy of Science and Technology (NAST).

SARAT SUNTHORNYOTHIN | Editorial Board Member | Prof. Sarat has nothing to disclose.

NATTAPOL SATHAVARODOM | Editorial Board Member | Prof. Nattapol has nothing to disclose.

CHNG CHIAW LING | Editorial Board Member | Dr. Ling receives SingHealh Duke-NUS Academic Medicine Research Grant.

TINT SWE LATT | Editorial Board Member | Prof. Latt has nothing to disclose.

KHOO CHIN MENG | Editorial Board Member | Dr. Meng has nothing to disclose.

NURAIN MOHD NOOR | Editorial Board Member | Dr. Noor is the current President of the Malaysian Endocrine and Metabolic Society (MEMS).

NATHANIEL S. ORILLAZA JR. | Editorial Board Member |

Dr. Orillaza receives grants from the Department of Science and Technology for research projects; the Department of Health for university-based programs and the National Academy of Science and Technology for research projects. He receives honoraria for faculty work at the AO Trauma Foundation, Department of Health hospitals and the National Academy of Science and Technology and receives honoraria for lectures from Viatris, Mundipharma, Menarini and Delex Pharma. He receives support for conference fees and travel expenses from the American Society for Surgery and the American Academy of Orthopedic Surgeons. He receives support for travel as course faculty from Viatris. He submitted patents for Telepresence Robot and Powered Respirator developed by UP SIBOL. He is a Research Officer and Council Member of the AO Trauma Philippines, a country delegate of the International Federation of Societies for Surgery of the Hand and a Regional Editor of the Journal of Hand Surgery Global Online, Malaysian Orthopedic Journal and the Journal of Hand Surgery Asian Pacific.  He is a stockholder of the Tagaytay Medical Center (without the right to practice).

PAUL MATTHEW D. PASCO| Editorial Board Member | Dr. Pasco receives grants from the Philippine Council for Health Research and Development (PCHRD).

CATHERINE LYNN T. SILAO| Editorial Board Member | Dr. Silao receives research grants from the Newborn Screening Reference Center and the National Institutes of Health. She receives fees for lectures from Nestle Philippines. She has pending patents for Methods and Means for Prognosticating the Occurrence of Pulmonary Complications in Leptospirosis and Early Diagnosis and Prognosis of Complicated Leptospirosis using Molecular Markers. She is a member of the Human Genome Education Committee. She is a stockholder of the Clinical Genetics and Genomic Counseling Care Services (CGGCCS) Inc.

ROGELIO V. TANGCO | Editorial Board Member | Dr. Tangco has nothing to disclose.

NGUYEN VAN TUAN | Editorial Board Member | Prof. Van Tuan receives grants from the Australian National Health and Medical Research Council through the University of Technology Sydney. He is also a recipient of the Amgen Competitive Grant Program through the University of Technology Sydney. He receives honoraria for lectures from Amgen, VT Health Care and Bridge Health Care. He receives support for attending meetings from Bridge Health Care Pty Ltd, Amgen and DKSH Pharma.

MYO WIN | Editorial Board Member | Prof. Win has nothing to disclose.

MARITA V.T. REYES | Ethics Adviser | Dr. Reyes receives consulting fees as a Technical Reviewer of study proposals of the Department of Science and Technology-Philippine Council for Health Research Development (DOST-PCHRD). She is the Chair of the Health Technology Assessment Council.

AMADO O. TANDOC III | Editorial Coordinator | Dr. Tandoc receives fees as a Consultant Editor of the Scientific Proceedings of the Lung Center of the Philippines. He is a speaker and Treasurer of the Philippine Association of Medical Journal Editors (PAMJE).